Biotechnology leads the charge with 3 stocks (GILD, VRTX, REGN) recently rated strong buy by analysts. Financials also gained significant momentum following Monday upgrades for 3 banks (CFG, TFC, ZION). Vertex’s $625 target mean suggests substantial upside potential for these mega-cap healthcare leaders. However, Tuesday downgrades for (DAL, UAL) signal caution as analysts pivot away from major airline carriers starting today.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.